HMGA proteins as modulators of chromatin structure during transcriptional activation

Frontiers in Cell and Developmental Biology

Volumn 2, Issue MAR, 2014, Pages

  Ozturk, Nihan ^a   Singh, Indrabahadur ^a   Mehta, Aditi ^a   Braun, Thomas ^a   Barreto, Guillermo ^a  

^a MAX PLANCK INSTITUTE FOR HEART AND LUNG RESEARCH   (Germany)

Author keywords

Chromatin structure; Development and cancer; HMGA; Transcription

Indexed keywords

EID: 85023631515     PISSN: None     EISSN: 2296634X     Source Type: Journal    
DOI: 10.3389/fcell.2014.00005     Document Type: Review

References (116)

1. Anand, A., Chada, K. (2000). In vivo modulation of Hmgic reduces obesity. Nat. Genet. 24, 377-380. doi: 10.1038/74207.
2. Antequera, F. (2003). Structure, function and evolution of CpG island promoters. Cell. Mol. Life Sci. 60, 1647-1658. doi: 10.1007/s00018-003-2185-x.
3. Baldassarre, G., Fedele, M., Battista, S., Vecchione, A., Klein-Szanto, A. J. P., Santoro, M., et al. (2001). Onset of natural killer cell lymphomas in transgenic mice carrying a truncated HMGI-C gene by the chronic stimulation of the IL-2 and IL-15 pathway. Proc. Natl. Acad. Sci. U.S.A. 98, 7970-7975. doi: 10.1073/pnas.141224998.
4. Belotserkovskaya, R., Oh, S., Bondarenko, V. A., Orphanides, G., Studitsky, V. M., Reinberg, D. (2003). FACT facilitates transcription-dependent nucleosome alteration. Science 301, 1090-1093. doi: 10.1126/science.1085703.
5. Berlingieri, M. T., Manfioletti, G., Santoro, M., Bandiera, A., Visconti, R., Giancotti, V., et al. (1995). Inhibition of Hmgi-C protein-synthesis suppresses retrovirally induced neoplastic transformation of rat-thyroid cells. Mol. Cell. Biol. 15, 1545-1553.
6. Bouallaga, I., Massicard, S., Yaniv, M., Thierry, F. (2000). An enhanceosome containing the Jun B/Fra-2 heterodimer and the HMG-I(Y) architectural protein controls HPV 18 transcription. EMBO Rep. 1, 422-427. doi: 10.1093/embo-reports/kvd091.
7. Bouallaga, I., Teissier, S., Yaniv, M., Thierry, F. (2003). HMG-I(Y) and the CBP/p300 coactivator are essential for human papillomavirus type 18 enhanceosome transcriptional activity. Mol. Cell. Biol. 23, 2329-2340. doi: 10.1128/Mcb.23.7.2329-2340.2003.
8. Brants, J. R., Ayoubi, T. A. Y., Chada, K., Marchal, K., Van De Ven, W. J. M., Petit, M. M. R. (2004). Differential regulation of the insulin-like growth factor II mRNA-binding protein genes by architectural transcription factor HMGA2. FEBS Lett. 569, 277-283. doi: 10.1016/j.febslet.2004.05.075.
9. Bustin, M. (2001). Revised nomenclature for high mobility group (HMG) chromosomal proteins. Trends Biochem. Sci. 26, 152-153. doi: 10.1016/S0968-0004(00)01777-1.
10. Butler, J. E. F., Kadonaga, J. T. (2002). The RNA polymerase II core promoter: a key component in the regulation of gene expression. Genes Dev. 16, 2583-2592. doi: 10.1101/Gad.1026202.
11. Cao, X., Clavijo, C., Li, X., Lin, H. H., Chen, Y., Shih, H. M., et al. (2008). SUMOylation of HMGA2: selective destabilization of promyelocytic leukemia protein via proteasome. Mol. Cancer Ther. 7, 923-934. doi: 10.1158/1535-7163.mct-07-0540.
12. Caron, L., Bost, F., Prot, M., Hofman, P., Binetruy, B. (2005). A new role for the oncogenic high-mobility group A2 transcription factor in myogenesis of embryonic stem cells. Oncogene 24, 6281-6291. doi: 10.1038/sj.onc.1208781.
13. Casalino, L., Bakiri, L., Talotta, F., Weitzman, J. B., Fusco, A., Yaniv, M., et al. (2007). Fra-1 promotes growth and survival in RAS-transformed thyroid cells by controlling cyclin A transcription. EMBO J. 26, 1878-1890. doi: 10.1038/sj.emboj.7601617.
14. Catez, F., Hock, R. (2010). Binding and interplay of HMG proteins on chromatin: Lessons from live cell imaging. Biochim. Biophys. Acta Gene Regul. Mech. 1799, 15-27. doi: 10.1016/j.bbagrm.2009.11.001.
15. Catez, F., Yang, H., Tracey, K. J., Reeves, R., Misteli, T., Bustin, M. (2004). Network of dynamic interactions between histone H1 and high-mobility-group proteins in chromatin. Mol. Cell. Biol. 24, 4321-4328. doi: 10.1128/MCB.24.10.4321-4328.2004.
16. Chen, B., Young, J., Leng, F. F. (2010). DNA bending by the mammalian high-mobility group protein AT Hook 2. Biochemistry 49, 1590-1595. doi: 10.1021/Bi901881c.
17. Chiappetta, G., Avantaggiato, V., Visconti, R., Fedele, M., Battista, S., Trapasso, F., et al. (1996). High level expression of the HMGI (Y) gene during embryonic development. Oncogene 13, 2439-2446.
18. Chieffi, P., Battista, S., Barchi, M., Di Agostino, S., Pierantoni, G. M., Fedele, M., et al. (2002). HMGA1 and HMGA2 protein expression in mouse spermatogenesis. Oncogene 21, 3644-3650. doi: 10.1038/sj.onc.1205501.
19. Cleynen, I., Brants, J. R., Peeters, K., Deckers, R., Debiec-Rychter, M., Sciot, R., et al. (2007). HMGA2 regulates transcription of the Imp2 gene via an intronic regulatory element in cooperation with nuclear factor-kappaB. Mol. Cancer Res. 5, 363-372. doi: 10.1158/1541-7786.MCR-06-0331.
20. Cleynen, I., Van De Ven, W. J. (2008). The HMGA proteins: a myriad of functions (Review). Int. J. Oncol. 32, 289-305. Available online at: http://www.spandidos-publications.com/ijo/32/2/289.
21. Contreras, A., Hale, T. K., Stenoien, D. L., Rosen, J. M., Mancini, M. A., Herrera, R. E. (2003). The dynamic mobility of histone H1 is regulated by cyclin/CDK phosphorylation. Mol. Cell. Biol. 23, 8626-8636. doi: 10.1128/Mcb.23.23.8626-8636.2003.
22. Copley, M. R., Babovic, S., Benz, C., Knapp, D. J., Beer, P. A., Kent, D. G., et al. (2013). The Lin28b-let-7-Hmga2 axis determines the higher self-renewal potential of fetal haematopoietic stem cells. Nat. Cell Biol. 15, 916-925. doi: 10.1038/ncb2783.
23. Cui, T. J., Leng, F. F. (2007). Specific recognition of AT-Rich DNA sequences by the mammalian high mobility group-protein AT-hook 2: a SELEX study. Biochemistry 46, 13059-13066. doi: 10.1021/Bi701269s.
24. Deaton, A. M., Bird, A. (2011). CpG islands and the regulation of transcription. Genes Dev. 25, 1010-1022. doi: 10.1101/Gad.2037511.
25. Di Agostino, S., Fedele, M., Chieffi, P., Fusco, A., Rossi, P., Geremia, R., et al. (2004). Phosphorylation of high-mobility group protein A2 by Nek2 kinase during the first meiotic division in mouse spermatocytes. Mol. Biol. Cell 15, 1224-1232. doi: 10.1091/mbc. E03-09-0638.
26. Di Cello, F., Hillion, J., Hristov, A., Wood, L. J., Mukherjee, M., Schuldenfrei, A., et al. (2008). HMGA2 participates in transformation in human lung cancer. Mol. Cancer Res. 6, 743-750. doi: 10.1158/1541-7786.Mcr-07-0095.
27. Edberg, D. D., Adkins, J. N., Springer, D. L., Reeves, R. (2005). Dynamic and differential in vivo modifications of the isoform HMGA1a and HMGA1b chromatin proteins. J. Biol. Chem. 280, 8961-8973. doi: 10.1074/jbc. M407348200.
28. Edberg, D. D., Bruce, J. E., Siems, W. F., Reeves, R. (2004). In vivo posttranslational modifications of the high mobility group A1a proteins in breast cancer cells of differing metastatic potential. Biochemistry 43, 11500-11515. doi: 10.1021/bi049833i.
29. Elton, T. S., Reeves, R. (1986). Purification and postsynthetic modifications of Friend erythroleukemic cell high mobility group protein HMG-I. Anal. Biochem. 157, 53-62.
30. Esposito, F., Pierantoni, G. M., Battista, S., Melillo, R. M., Scala, S., Chieffi, P., et al. (2009). Interaction between HMGA1 and retinoblastoma protein is required for adipocyte differentiation. J. Biol. Chem. 284, 25993-26004. doi: 10.1074/jbc. M109.034280.
31. Esposito, F., Tornincasa, M., Chieffi, P., De Martino, I., Pierantoni, G. M., Fusco, A. (2010). High-Mobility Group A1 proteins regulate p53-mediated transcription of Bcl-2 Gene. Cancer Res. 70, 5379-5388. doi: 10.1158/0008-5472.Can-09-4199.
32. Esposito, F., Tornincasa, M., Federico, A., Chiappetta, G., Pierantoni, G. M., Fusco, A. (2012). High-mobility group A1 protein inhibits p53-mediated intrinsic apoptosis by interacting with Bcl-2 at mitochondria. Cell Death Dis. 3:e383. doi: 10.1038/cddis.2012.126.
33. Evans, J. N., Zajicek, J., Nissen, M. S., Munske, G., Smith, V., Reeves, R. (1995). 1H and 13C NMR assignments and molecular modelling of a minor groove DNA-binding peptide from the HMG-I protein. Int. J. Pept. Protein Res. 45, 554-560.
34. Fedele, M., Battista, S., Manfioletti, G., Croce, C. M., Giancotti, V., Fusco, A. (2001). Role of the high mobility group A proteins in human lipomas. Carcinogenesis 22, 1583-1591. doi: 10.1093/carcin/22.10.1583.
35. Fedele, M., Fidanza, V., Battista, S., Pentimalli, F., Klein-Szanto, A. J. P., Visone, R., et al. (2006a). Haploinsufficiency of the Hmga1 gene causes cardiac hypertrophy and myelo-lymphoproliferative disorders in mice. Cancer Res. 66, 2536-2543. doi: 10.1158/0008-5472.Can-05-1889.
36. Fedele, M., Visone, R., De Martino, I., Palmieri, D., Valentino, T., Esposito, F., et al. (2011). Expression of a truncated Hmga1b gene induces gigantism, lipomatosis and B-cell lymphomas in mice. Eur. J. Cancer 47, 470-478. doi: 10.1016/j.ejca.2010.09.045.
37. Fedele, M., Visone, R., De Martino, I., Troncone, G., Palmieri, D., Battista, S., et al. (2006b). HMGA2 induces pituitary tumorigenesis by enhancing E2F1 activity. Cancer Cell 9, 459-471. doi: 10.1016/j.ccr.2006.04.024.
38. Foti, D., Chiefari, E., Fedele, M., Iuliano, R., Brunetti, L., Paonessa, F., et al. (2005). Lack of the architectural factor HMGA1 causes insulin resistance and diabetes in humans and mice. Nat. Med. 11, 765-773. doi: 10.1038/nm1254.
39. Foti, D., Iuliano, R., Chiefari, E., Brunetti, A. (2003). A nucleoprotein complex containing Sp1, C/EBP beta, and HMGI-Y controls human insulin receptor gene transcription. Mol. Cell. Biol. 23, 2720-2732. doi: 10.1128/MCB.23.8.2720-2732.2003.
40. Frasca, F., Rustighi, A., Malaguarnera, R., Altamura, S., Vigneri, P., Del Sal, G., et al. (2006). HMGA1 inhibits the function of p53 family members in thyroid cancer cells. Cancer Res. 66, 2980-2989. doi: 10.1158/0008-5472.Can-05-2637.
41. French, S. W., Schmidt, M. C., Glorioso, J. C. (1996). Involvement of a high-mobility-group protein in the transcriptional activity of herpes simplex virus latency-active promoter 2. Mol. Cell. Biol. 16, 5393-5399.
42. Fusco, A., Fedele, M. (2007). Roles of HMGA proteins in cancer. Nat. Rev. Cancer 7, 899-910. doi: 10.1038/Nrc2271.
43. Giancotti, V., Berlingieri, M. T., Difiore, P. P., Fusco, A., Vecchio, G., Crane-Robinson, C. (1985). Changes in nuclear proteins on transformation of rat epithelial thyroid cells by a murine sarcoma retrovirus. Cancer Res. 45, 6051-6057.
44. Gohlke, J., Scholz, C. J., Kneitz, S., Weber, D., Fuchs, J., Hedrich, R., et al. (2013). DNA methylation mediated control of gene expression is critical for development of crown gall tumors. PLoS Genet. 9:e1003267. doi: 10.1371/journal.pgen.1003267.
45. Golestaneh, N., Mishra, B. (2005). TGF-beta, neuronal stem cells and glioblastoma. Oncogene 24, 5722-5730. doi: 10.1038/sj.onc.1208925.
46. Ha, M., Ng, D. W. K., Li, W. H., Chen, Z. J. (2011). Coordinated histone modifications are associated with gene expression variation within and between species. Genome Res. 21, 590-598. doi: 10.1101/gr.116467.110.
47. Hammond, S. M., Sharpless, N. E. (2008). HMGA2, MicroRNAs, and Stem Cell Aging. Cell 135, 1013-1016. doi: 10.1016/j.cell.2008.11.026.
48. Hirning-Folz, U., Wilda, M., Rippe, V., Bullerdiek, J., Hameister, H. (1998). The expression pattern of the Hmgic gene during development. Genes Chromosomes Cancer 23, 350-357. doi: 10.1002/(Sici)1098-2264(199812)23:4<350::Aid-Gcc10>3.0.Co;2-E.
49. Hock, R., Furusawa, T., Ueda, T., Bustin, M. (2007). HMG chromosomal proteins in development and disease. Trends Cell Biol. 17, 72-79. doi: 10.1016/j.tcb.2006.12.001.
50. Ikushima, H., Todo, T., Ino, Y., Takahashi, M., Miyazawa, K., Miyazono, K. (2009). Autocrine TGF-beta signaling maintains tumorigenicity of glioma-initiating cells through Sry-related HMG-box factors. Cell Stem Cell 5, 504-514. doi: 10.1016/j.stem.2009.08.018.
51. Ju, B. G., Lunyak, V. V., Perissi, V., Garcia-Bassets, I., Rose, D. W., Glass, C. K., et al. (2006). A topoisomerase II beta-mediated dsDNA break required for regulated transcription. Science 312, 1798-1802. doi: 10.1126/science.1127196.
52. Kalluri, R., Weinberg, R. A. (2009). The basics of epithelial-mesenchymal transition. J. Clin. Invest. 119, 1420-1428. doi: 10.1172/Jci39104.
53. Karlic, R., Chung, H. R., Lasserre, J., Vlahovicek, K., Vingron, M. (2010). Histone modification levels are predictive for gene expression. Proc. Natl. Acad. Sci. U.S.A. 107, 2926-2931. doi: 10.1073/pnas.0909344107.
54. Kishi, Y., Fujii, Y., Hirabayashi, Y., Gotoh, Y. (2012). HMGA regulates the global chromatin state and neurogenic potential in neocortical precursor cells. Nat. Neurosci. 15, 1127-1133. doi: 10.1038/Nn.3165.
55. Kumar, M. S., Armenteros-Monterroso, E., East, P., Chakravorty, P., Matthews, N., Winslow, M. M., et al. (2013). HMGA2 functions as a competing endogenous RNA to promote lung cancer progression. Nature 505, 212-217. doi: 10.1038/nature12785.
56. Landolin, J. M., Johnson, D. S., Trinklein, N. D., Aldred, S. F., Medina, C., Shulha, H., et al. (2010). Sequence features that drive human promoter function and tissue specificity. Genome Res. 20, 890-898. doi: 10.1101/gr.100370.109.
57. Lee, Y. S., Dutta, A. (2007). The tumor suppressor microRNA let-7 represses the HMGA2 oncogene. Genes Dev. 21, 1025-1030. doi: 10.1101/Gad.1540407.
58. Lehn, D. A., Elton, T. S., Johnson, K. R., Reeves, R. (1988). A conformational study of the sequence specific binding of Hmg-I (Y) with the Bovine Interleukin-2 Cdna. Biochem. Int. 16, 963-971.
59. Levine, M., Tjian, R. (2003). Transcription regulation and animal diversity. Nature 424, 147-151. doi: 10.1038/Nature01763.
60. Li, O., Vasudevan, D., Davey, C. A., Droge, P. (2006). High-level expression of DNA architectural factor HMGA2 and its association with nucleosomes in human embryonic stem cells. Genesis 44, 523-529. doi: 10.1002/dvg.20242.
61. Li, Z. Z., Gilbert, J. A., Zhang, Y. Y., Zhang, M. S., Qiu, Q., Ramanujan, K., et al. (2012). An HMGA2-IGF2BP2 Axis regulates myoblast proliferation and myogenesis. Dev. Cell 23, 1176-1188. doi: 10.1016/j.devcel.2012.10.019.
62. Liu, J., Schiltz, J. F., Ashar, H. R., Chada, K. K. (2003). Hmga1 is required for normal sperm development. Mol. Reprod. Dev. 66, 81-89. doi: 10.1002/mrd.10323.
63. Malini, E., Maurizio, E., Bembich, S., Sgarra, R., Edomi, P., Manfioletti, G. (2011). HMGA Interactome: new insights from phage display technology. Biochemistry 50, 3462-3468. doi: 10.1021/Bi200101f.
64. Massimi, I., Guerrieri, F., Petroni, M., Veschi, V., Truffa, S., Screpanti, I., et al. (2013). The HMGA1 protoncogene frequently deregulated in cancer is a transcriptional target of E2F1. Mol. Carcinog. 52, 526-534. doi: 10.1002/Mc.21887.
65. Monzen, K., Ito, Y., Naito, A. T., Kasai, H., Hiroi, Y., Hayashi, D., et al. (2008). A crucial role of a high mobility group protein HMGA2 in cardiogenesis. Nat. Cell Biol. 10, 567-574. doi: 10.1038/Ncb1719.
66. Morishita, A., Zaidi, M. R., Mitoro, A., Sankarasharma, D., Szabolcs, M., Okada, Y., et al. (2013). HMGA2 is a driver of tumor metastasis. Cancer Res. 73, 4289-4299. doi: 10.1158/0008-5472.CAN-12-3848.
67. Munshi, N., Agalioti, T., Lomvardas, S., Merika, M., Chen, G. Y., Thanos, D. (2001). Coordination of a transcriptional switch by HMGI(Y) acetylation. Science 293, 1133-1136. doi: 10.1126/science.293.5532.1133.
68. Munshi, N., Merika, M., Yie, J., Senger, K., Chen, G., Thanos, D. (1998). Acetylation of HMG I(Y) by CBP turns offIFN beta expression by disrupting the enhanceosome. Mol. Cell 2, 457-467.
69. Munshi, N., Yie, Y., Merika, M., Senger, K., Lomvardas, S., Agalioti, T., et al. (1999). The IFN-beta enhancer: a paradigm for understanding activation and repression of inducible gene expression. Cold Spring Harb. Symp. Quant. Biol. 64, 149-159.
70. Natarajan, S., Hombach-Klonisch, S., Droge, P., Klonisch, T. (2013). HMGA2 Inhibits Apoptosis through Interaction with ATR-CHK1 Signaling Complex in Human Cancer Cells. Neoplasia 15, 263-280. doi: 10.1593/Neo.121988.
71. Nishino, J., Kim, I., Chada, K., Morrison, S. J. (2008). Hmga2 promotes neural stem cell self-renewal in young but not old mice by reducing p16Ink4a and p19Arf Expression. Cell 135, 227-239. doi: 10.1016/j.cell.2008.09.017.
72. Nissen, M. S., Langan, T. A., Reeves, R. (1991). Phosphorylation by cdc2 kinase modulates DNA binding activity of high mobility group I nonhistone chromatin protein. J. Biol. Chem. 266, 19945-19952.
73. Palmieri, D., Valentino, T., D'angelo, D., De Martino, I., Postiglione, I., Pacelli, R., et al. (2011). HMGA proteins promote ATM expression and enhance cancer cell resistance to genotoxic agents. Oncogene 30, 3024-3035. doi: 10.1038/Onc.2011.21.
74. Pandit, K. V., Corcoran, D., Yousef, H., Yarlagadda, M., Tzouvelekis, A., Gibson, K. F., et al. (2010). Inhibition and Role of let-7d in Idiopathic Pulmonary Fibrosis. Am. J. Respir. Crit. Care Med. 182, 220-229. doi: 10.1164/rccm.200911-1698OC.
75. Panne, D. (2008). The enhanceosome. Curr. Opin. Struct. Biol. 18, 236-242. doi: 10.1016/j.sbi.2007.12.002.
76. Panne, D., Maniatis, T., Harrison, S. C. (2007). An atomic model of the interferon-beta enhanceosome. Cell 129, 1111-1123. doi: 10.1016/j.cell.2007.05.019.
77. Pentimalli, F., Palmieri, D., Pacelli, R., Garbi, C., Cesari, R., Martin, E., et al. (2008). HMGA1 protein is a novel target of the ATM kinase. Eur. J. Cancer 44, 2668-2679. doi: 10.1016/j.ejca.2008.07.033.
78. Pfannkuche, K., Summer, H., Li, O., Hescheler, J., Droge, P. (2009). The High Mobility Group Protein HMGA2: a co-regulator of chromatin structure and pluripotency in stem cells? Stem Cell Rev. Rep. 5, 224-230. doi: 10.1007/s12015-009-9078-9.
79. Pierantoni, G. M., Fedele, M., Pentimalli, F., Benvenuto, G., Pero, R., Viglietto, G., et al. (2001). High mobility group I (Y) proteins bind HIPK2, a serine-threonine kinase protein which inhibits cell growth. Oncogene 20, 6132-6141. doi: 10.1038/sj.onc.1204635.
80. Pierantoni, G. M., Rinaldo, C., Esposito, F., Mottolese, M., Soddu, S., Fusco, A. (2006). High Mobility Group A1 (HMGA1) proteins interact with p53 and inhibit its apoptotic activity. Cell Death Differ. 13, 1554-1563. doi: 10.1038/sj.cdd.4401839.
81. Pierantoni, G. M., Rinaldo, C., Mottolese, M., Di Benedetto, A., Esposito, F., Soddu, S., et al. (2007). High-mobility group A1 inhibits p53 by cytoplasmic relocalization of its proapoptotic activator HIPK2. J. Clin. Invest. 117, 693-702. doi: 10.1172/Jc129852.
82. Ramirez-Carrozzi, V. R., Braas, D., Bhatt, D. M., Cheng, C. S., Hong, C., Doty, K. R., et al. (2009). A unifying model for the selective regulation of inducible transcription by CpG Islands and nucleosome remodeling. Cell 138, 114-128. doi: 10.1016/j.cell.2009.04.020.
83. Reeves, R. (2001). Molecular biology of HMGA proteins: hubs of nuclear function. Gene 277, 63-81. doi: 10.1016/S0378-1119(01)00689-8.
84. Reeves, R. (2010). Nuclear functions of the HMG proteins. Biochim. Biophys. Acta Gene Regul. Mech. 1799, 3-14. doi: 10.1016/j.bbagrm.2009.09.001.
85. Reeves, R., Edberg, D. D., Li, Y. (2001). Architectural transcription factor HMGI(Y) promotes tumor progression and mesenchymal transition of human epithelial cells. Mol. Cell. Biol. 21, 575-594. doi: 10.1128/Mcb.21.2.575-594.2001.
86. Ren, J., Wen, L., Gao, X., Jin, C., Xue, Y., Yao, X. (2009). DOG 1.0: illustrator of protein domain structures. Cell Res. 19, 271-273. doi: 10.1038/cr.2009.6.
87. Schulze, A., Zerfass, K., Spitkovsky, D., Middendorp, S., Berges, J., Helin, K., et al. (1995). Cell-cycle regulation of the cyclin-a gene promoter is mediated by a variant E2f site. Proc. Natl. Acad. Sci. U.S.A. 92, 11264-11268. doi: 10.1073/pnas.92.24.11264.
88. Schwabish, M. A., Struhl, K. (2006). Asf1 mediates histone eviction and deposition during elongation by RNA polymerase II. Mol. Cell 22, 415-422. doi: 10.1016/j.molcel.2006.03.014.
89. Schwanbeck, R., Manfioletti, G., Wisniewski, J. R. (2000). Architecture of high mobility group protein I-C.DNA complex and its perturbation upon phosphorylation by Cdc2 kinase. J. Biol. Chem. 275, 1793-1801. doi: 10.1074/jbc.275.3.1793.
90. Sgarra, R., Diana, F., Bellarosa, C., Dekleva, V., Rustighi, A., Toller, M., et al. (2003). During apoptosis of tumor cells HMGA1a protein undergoes methylation: identification of the modification site by mass spectrometry. Biochemistry 42, 3575-3585. doi: 10.1021/Bi0273381.
91. Sgarra, R., Lee, J., Tessari, M. A., Altamura, S., Spolaore, B., Giancotti, V., et al. (2006). The AT-hook of the chromatin architectural transcription factor high mobility group A1a is arginine-methylated by protein arginine methyltransferase 6. J. Biol. Chem. 281, 3764-3772. doi: 10.1074/jbc. M510231200.
92. Sgarra, R., Rustighi, A., Tessari, M. A., Di Bernardo, J., Altamura, S., Fusco, A., et al. (2004). Nuclear phosphoproteins HMGA and their relationship with chromatin structure and cancer. FEBS Lett. 574, 1-8. doi: 10.1016/j.febslet.2004.08.013.
93. Shell, S., Park, S. M., Radjabi, A. R., Schickel, R., Kistner, E. O., Jewell, D. A., et al. (2007). Let-7 expression defines two differentiation stages of cancer. Proc. Natl. Acad. Sci. U.S.A. 104, 11400-11405. doi: 10.1073/pnas.0704372104.
94. Snijders, A. P., Pongdam, S., Lambert, S. J., Wood, C. M., Baldwin, J. P., Dickman, M. J. (2008). Characterization of post-translational modifications of the linker histones H1 and H5 from chicken erythrocytes using mass spectrometry. J. Proteome Res. 7, 4326-4335. doi: 10.1021/pr800260a.
95. Sun, M., Song, C. X., Huang, H., Frankenberger, C. A., Sankarasharma, D., Gomes, S., et al. (2013). HMGA2/TET1/HOXA9 signaling pathway regulates breast cancer growth and metastasis. Proc. Natl. Acad. Sci. U.S.A. 110, 9920-9925. doi: 10.1073/pnas.1305172110.
96. Thiery, J. P., Sleeman, J. P. (2006). Complex networks orchestrate epithelial-mesenchymal transitions. Nat. Rev. Mol. Cell Biol. 7, 131-142. doi: 10.1038/nrm1835.
97. Thornton, J. E., Gregory, R. I. (2012). How does Lin28 let-7 control development and disease? Trends Cell Biol. 22, 474-482. doi: 10.1016/j.tcb.2012.06.001.
98. Thuault, S., Tan, E. J., Peinado, H., Cano, A., Heldin, C. H., Moustakas, A. (2008). HMGA2 and Smads Co-regulate SNAIL1 expression during induction of epithelial-to-mesenchymal transition. J. Biol. Chem. 283, 33437-33446. doi: 10.1074/jbc. M802016200.
99. Thuault, S., Valcourt, U., Petersen, M., Manfioletti, G., Heldin, C. H., Moustakas, A. (2006). Transforming growth factor-beta employs HMGA2 to elicit epithelial-mesenchymal transition. J. Cell Biol. 174, 175-183. doi: 10.1083/jcb.200512110.
100. Vallone, D., Battista, S., Pierantoni, G. M., Fedele, M., Casalino, L., Santoro, M., et al. (1997). Neoplastic transformation of rat thyroid cells requires the junB and fra-1 gene induction which is dependent on the HMGI-C gene product. EMBO J. 16, 5310-5321. doi: 10.1093/emboj/16.17.5310.
101. Wang, D. Z., Ray, P., Boothby, M. (1995). Interleukin 4-inducible phosphorylation of HMG-I(Y) is inhibited by rapamycin. J. Biol. Chem. 270, 22924-22932.
102. Watanabe, S., Ueda, Y., Akaboshi, S., Hino, Y., Sekita, Y., Nakao, M. (2009). HMGA2 Maintains Oncogenic RAS-Induced epithelial-mesenchymal transition in human pancreatic cancer cells. Am. J. Pathol. 174, 854-868. doi: 10.2353/ajpath.2009.080523.
103. Winslow, M. M., Dayton, T. L., Verhaak, R. G. W., Kim-Kiselak, C., Snyder, E. L., Feldser, D. M., et al. (2011). Suppression of lung adenocarcinoma progression by Nkx2-1. Nature 473, U101-U120. doi: 10.1038/Nature09881.
104. Winter, N., Nimzyk, R., Bosche, C., Meyer, A., Bullerdiek, J. (2011). Chromatin Immunoprecipitation to Analyze DNA Binding Sites of HMGA2. PLoS ONE 6:e18837. doi: 10.1371/journal.pone.0018837.
105. Wood, L. J., Maher, J. F., Bunton, T. E., Resar, L. M. S. (2000). The oncogenic properties of the HMG-I gene family. Cancer Res. 60, 4256-4261.
106. Wu, J. J., Wei, J. J. (2013). HMGA2 and high-grade serous ovarian carcinoma. J. Mol. Med. 91, 1155-1165. doi: 10.1007/s00109-013-1055-8.
107. Wu, J. J., Liu, Z. J., Shao, C. S., Gong, Y. Q., Hernando, E., Lee, P., et al. (2011). HMGA2 Overexpression-induced ovarian surface epithelial transformation is mediated through regulation of EMT Genes. Cancer Res. 71, 349-359. doi: 10.1158/0008-5472.Can-10-2550.
108. Xu, M. Y., Sharma, P., Pan, S. Q., Malik, S., Roeder, R. G., Martinez, E. (2011). Core promoter-selective function of HMGA1 and mediator in initiator-dependent transcription. Genes Dev. 25, 2513-2524. doi: 10.1101/gad.177360.111.
109. Yie, J., Merika, M., Munshi, N., Chen, G., Thanos, D. (1999). The role of HMG I(Y) in the assembly and function of the IFN-beta enhanceosome. EMBO J. 18, 3074-3089. doi: 10.1093/emboj/18.11.3074.
110. Zha, L., Wang, Z. W., Tang, W. X., Zhang, N., Liao, G., Huang, Z. (2012). Genome-wide analysis of HMGA2 transcription factor binding sites by ChIP on chip in gastric carcinoma cells. Mol. Cell. Biochem. 364, 243-251. doi: 10.1007/s11010-012-1224-z.
111. Zhang, Q., Wang, Y. (2007). Homeodomain-interacting protein kinase-2 (HIPK2) phosphorylates HMGA1a at Ser-35, Thr-52, and Thr-77 and modulates its DNA binding affinity. J. Proteome Res. 6, 4711-4719. doi: 10.1021/pr700571d.
112. Zhang, Q., Zhang, K., Zou, Y., Perna, A., Wang, Y. (2007). A quantitative study on the in vitro and in vivo acetylation of high mobility group A1 proteins. J. Am. Soc. Mass Spectrom. 18, 1569-1578. doi: 10.1016/j.jasms.2007.05.020.
113. Zhang, Y., Fatima, N., Dufau, M. L. (2005). Coordinated changes in DNA methylation and histone modifications regulate silencing/derepression of luteinizing hormone receptor gene transcription. Mol. Cell. Biol. 25, 7929-7939. doi: 10.1128/Mcb.25.18.7929-7939.2005.
114. Zhao, K., Kas, E., Gonzalez, E., Laemmli, U. K. (1993). Sar-dependent mobilization of histone H1 by Hmg-I/Y in-Vitro - Hmg-I/Y Is Enriched in H1-depleted chromatin. EMBO J. 12, 3237-3247.
115. Zhou, X. J., Benson, K. F., Ashar, H. R., Chada, K. (1995). Mutation Responsible for the Mouse Pygmy Phenotype in the Developmentally-Regulated Factor Hmgi-C. Nature 376, 771-774. doi: 10.1038/376771a0.
116. Zhu, H., Shyh-Chang, N., Segre, A. V., Shinoda, G., Shah, S. P., Einhorn, W. S., et al. (2011). The Lin28/let-7 axis regulates glucose metabolism. Cell 147, 81-94. doi: 10.1016/j.cell.2011.08.033.